logo
AST SpaceMobile: A High-Risk, High-Reward Play on the Future of Connectivity

AST SpaceMobile: A High-Risk, High-Reward Play on the Future of Connectivity

Globe and Mail15 hours ago

Forget what you thought you knew about satellite phones. While market attention remains fixed on artificial intelligence and quantum computing, a Texas-based company is making significant strides in its mission to revolutionize global internet access.
AST SpaceMobile (NASDAQ: ASTS) is on the verge of launching a commercial space-based cellular network that communicates directly with the smartphone in your pocket. After a volatile journey since its 2021 public debut, a series of critical developments in 2025 are bringing its ambitious vision into sharp focus. Here's what you need to know about this high-profile space stock.
A work in progress
AST SpaceMobile's first-quarter 2025 results underscored the capital demands of its ambitious mission, reporting a $63 million operating loss driven by heavy research and development (R&D) and manufacturing investments. But that figure now comes with important context.
In a pivotal breakthrough, the company secured a term sheet granting it long-term (80-plus years) access to 45 megahertz (MHz) of premium lower mid-band spectrum in North America through a settlement with Ligado. To fund the deal, AST also lined up $550 million in non-recourse financing.
This is a game-changing development. It locks in a vital strategic asset and injects substantial capital without shareholder dilution, resolving a major financial overhang and providing the company with a much clearer path forward.
Armed with this backing, AST's projections look increasingly credible: gateway equipment bookings of roughly $10 million per quarter and its first major revenue surge, estimated at $50 million to $75 million, in the second half of 2025. The transition from R&D to commercial deployment is no longer theoretical. It's in motion.
A market opportunity redefined
The global mobile connectivity market is a behemoth, generating over $135 billion in 2024. Yet, vast swathes of the planet and billions of people remain disconnected due to the economic and geographical limitations of terrestrial cell towers.
AST SpaceMobile aims to close this digital divide by transforming space into the ultimate cell tower. The company's next-generation Block 2 BlueBird satellites, featuring massive 2,400-square-foot communications arrays, are engineered to deliver up to 10 times the bandwidth of their predecessors.
This technological leap represents a fundamental reimagining of telecommunications infrastructure, offering solutions to challenges such as rural tower maintenance, the high cost of 5G densification, and network outages caused by natural disasters.
A deepening competitive moat
AST SpaceMobile's core advantage is its ability to deliver broadband directly to standard, unmodified smartphones -- eliminating the need for specialized terminals. Unlike traditional satellite internet providers, AST enables seamless roaming between terrestrial and space-based networks, creating a user experience that mirrors existing mobile coverage.
That advantage just became more defensible. The company's new long-term agreement for premium L-Band spectrum is a strategic coup, establishing a regulatory and resource barrier that few can match. Combined with a growing patent portfolio and spectrum-sharing deals with major carriers like AT&T and Verizon, AST is locking in a lead that's increasingly hard to close.
But urgency is rising. SpaceX's Starlink may be limited to text messaging in its Direct-to-Cell beta, yet it has already completed its first-generation satellite constellation -- proof of its rapid deployment capability. To rival AST's broadband ambitions, Starlink must still secure new spectrum access and enhance its hardware. However, its momentum highlights the importance of AST's early mover edge.
Other players are also closing in. Lynk Global, backed by SES, is advancing commercial operations, signaling that the race for direct-to-device dominance is well underway.
A valuation demanding a long-term view
As of mid-June 2025, AST SpaceMobile has surged 81% year to date, lifting its market cap above $12.5 billion. For a company just beginning to generate revenue, this valuation is undeniably priced for the future.
Traditional satellite operators, such as Iridium, offer limited benchmarks. A better comparison might be early-stage biotech or deep-tech firms -- businesses where value hinges on scalability and binary execution milestones. If AST succeeds in launching its commercial service and captures even a modest share of its massive addressable market, today's valuation may prove conservative.
The upcoming launch cadence is pivotal. AST plans five orbital launches over the next six to nine months, beginning in July 2025. The goal is to enable continuous cellular broadband coverage across the U.S., Europe, and Japan by 2026. Execution on that timeline could mark the company's transition from promise to reality, thereby justifying the market's confidence.
Risks remain, but so does the asymmetric upside
The bullish case for AST SpaceMobile has sharpened. With financing secured and spectrum access locked in, the investment thesis now rests squarely on operational execution.
The biggest risks are no longer financial -- they're physical. Satellite manufacturing is complex, and any launch failure could derail the rollout timeline. Regulatory headwinds may also emerge, particularly as astronomers raise concerns about light pollution and radio interference from growing satellite constellations.
Still, for investors with high risk tolerance and a long-term horizon, AST offers a rare asymmetric opportunity. The company has cleared major technical, strategic, and financial hurdles. Now comes the hardest part: executing at scale.
Success would mean not just delivering broadband from space, but reshaping the entire architecture of global connectivity. That's a transformation worth watching closely.
Should you invest $1,000 in AST SpaceMobile right now?
Before you buy stock in AST SpaceMobile, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and AST SpaceMobile wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,702!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $870,207!*
Now, it's worth noting Stock Advisor 's total average return is988% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of June 9, 2025

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

3 Nuclear ETFs to Watch as U.S. Policy Sparks a Surge
3 Nuclear ETFs to Watch as U.S. Policy Sparks a Surge

Globe and Mail

time27 minutes ago

  • Globe and Mail

3 Nuclear ETFs to Watch as U.S. Policy Sparks a Surge

While investors have generally been cautious regarding green energy since the presidential election last November, the Trump administration has recently provided multiple signals that it intends to boost domestic nuclear energy by a significant amount. In May, the president signed a series of executive orders aiming to facilitate the construction of nuclear plants on public lands, grow U.S. uranium mining operations, and, controversially, revisit exposure limits for ionizing radiation. The exact impact of these orders remains to be seen, but investors have good reason now to expect movement in companies linked to nuclear energy, particularly amid rising demand related to AI usage. Individual pure-play stocks like Denison Mines Corp. (TSE: DML) and even larger energy firms with a nuclear arm such as PG&E Corp. (NYSE: PCG) could benefit from recent government action. But investors may not wish to make a bet on individual companies while the regulatory landscape is shifting so dramatically. Instead, a number of high-quality nuclear energy exchange-traded funds (ETFs) provide a diversified alternative and excellent, broad exposure to the industry. This Uranium ETF Offers Growth and Dividends Too [content-module:CompanyOverview|NYSEARCA:URNM] Though it's down more than 2% in the last year, the Sprott Uranium Miners ETF (NYSEARCA: URNM) has surged by nearly 19% in the past month. With roughly 36 holdings, URNM is one of the more consolidated portfolios among the relatively small number of nuclear energy ETFs available. As such, investors should expect that a small number of positions will occupy outsized portions of the fund, the top two names are roughly 30% of invested assets, for example. As a uranium miners fund, URNM provides exposure to one corner of the broader nuclear energy space. The fund sets itself apart by investing a sizable portion of its asset base, nearly 12%, in the Sprott Physical Uranium Trust, a fund dedicated to holding physical uranium. Investors should also note that not every company in URNM's portfolio is exclusively dedicated to uranium mining; the fund's target index aims to include companies devoting at least 50% of their assets to the uranium mining industry. URNM's mix of assets allows it to pay an attractive dividend yield of 3.13%, making it a good choice for investors seeking both capital appreciation and passive income potential. And with an expense ratio of 0.75%, URNM is solidly in the middle when it comes to fees across the nuclear energy fund space. Global X Uranium ETF Powers Ahead With 29% Gain [content-module:CompanyOverview|NYSEARCA:URA] The Global X Uranium ETF (NYSEARCA: URA) has outperformed URNM above with one-year returns near 9% and a rally of 29% in the last month. It also enjoys substantially higher trading volumes, with a one-month average of more than 3.6 million shares. URA has close to 50 holdings and is not limited to uranium mining firms, although it is highly concentrated, with the top position occupying nearly a quarter of the portfolio. URA may be among the best options for exposure to the broad uranium industry, including both mining firms and companies involved in designing and building nuclear energy components. It has a focus across developed markets, so companies in countries heavily involved in the industry, including Canada and South Korea, among others, have prominent positions. Investors might need to know that URA has a history of fairly wide price swings, including a drop of roughly 50% from November 2024 through April 2025. Still, its expense ratio of 0.69% makes it one of the cheapest ETFs to focus exclusively on the nuclear energy space. This Nuclear ETF Is Quietly Crushing the Market [content-module:CompanyOverview|NYSEARCA:NUKZ] With an even more impressive return of 54% in the last year (and a very strong 21% boost in the past month), the Range Nuclear Renaissance Index ETF (NYSEARCA: NUKZ) targets a slightly different space than the two funds above. NUKZ is focused on companies operating within the advanced reactor, utilities, construction & services, and fuel industries. Its 45-holding portfolio is similarly focused, but assets are distributed somewhat more evenly across these positions: the largest holding is under 10% for NUKZ. NUKZ also has the advantage of a truly global focus, although its relatively smaller asset base and trading volume may offset this in comparison with URNM and URA. Investors should also not expect much by way of dividend payments from NUKZ, and its fee is slightly higher at 0.85%. Still, if it can maintain recent momentum, these other factors may not matter much to investors. Where Should You Invest $1,000 Right Now? Before you make your next trade, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list. They believe these five stocks are the five best companies for investors to buy now...

Leonard Lauder, billionaire heir to cosmetics empire, dies at 92
Leonard Lauder, billionaire heir to cosmetics empire, dies at 92

CTV News

time5 hours ago

  • CTV News

Leonard Lauder, billionaire heir to cosmetics empire, dies at 92

Leonard Lauder, the eldest son of cosmetics pioneers Estée and Joseph H. Lauder and the former head of cosmetics giant Estée Lauder Companies, seen here in New York on May 5, 2014 has died age 92, according to an announcement by the company. Dennis Van Tine/via CNN Newsource Leonard Lauder, the eldest son of cosmetics pioneers Estée and Joseph H. Lauder and the former head of cosmetics giant Estée Lauder Companies, died on Saturday, according to an announcement by the company. He was 92. 'Throughout his life, my father worked tirelessly to build and transform the beauty industry, pioneering many of the innovations, trends, and best practices that are foundational to the industry today,' Leonard's son William P. Lauder, who serves as chairman of the company's board of directors, said in the statement. Born to a Jewish family in New York City, Leonard Lauder as a boy would join his mother on sales calls in salons and helped her pack boxes of powder and cleansing oils. He would later attend and graduate from Columbia University's School of Business after serving as a lieutenant in the US Navy for three years. He formally joined Estée Lauder at age 25 in 1958, when the company had just a handful of employees and under $1 million in sales. Estée Lauder Companies would grow into a global empire with a portfolio that includes Clinique, La Mer, The Ordinary, MAC Cosmetics and Bobbi Brown Cosmetics. Among his many roles included serving as president for 23 years, beginning in 1972, and chief executive from 1982 to 1999. He was named chairman in 1995 and held the role until 2009, according to the company. In 1995, Lauder took the company public on the New York Stock Exchange at $26 a share. The Estée Lauder Companies Inc. (EL) now has a market capitalization of about $24.3 billion. According to Bloomberg's Billionaire Index, Lauder had a personal net worth of $15.6 billion. When asked what he would want to be remembered for during a 2020 interview with CBS News, Lauder replied: 'He listened … and he was kind.' Within 24 hours of meeting Lauder, one could expect intimate, often handwritten, notes from the beauty pioneer. It was a sales technique that resembled the professional style of his mother, who was also known for believing business was about developing and maintaining relationships and making people feel important. 'At the beginning, we never advertised … we gave out samples,' he told David Rubenstein, the co-founder of the Carlyle Group, in 2021. 'We gave out samples that were large enough. If you give a customer a sample of a product and they like it, they come back and buy it again and again and again— that's what builds the business.' Lauder has been credited with creating 'the lipstick index' during the economic downturn following the attacks on September 11, 2001. He noticed that the purchase of cosmetics, especially lipsticks, tended to be inversely related to the economy because women replaced more expensive purchases with small pick-me-ups. In the fall of 2001, US lipstick sales increased by 11%. And back during the Great Depression, cosmetics sales overall increased by 25%. Lauder was also a devoted philanthropist and art collector. In 2013, he pledged a 78-piece collection of cubist art to the Metropolitan Museum of Art in New York City — the largest single philanthropic gift in the Met's history, according to Estée Lauder. He also established a research center for modern art at the Met, which supported fellowships, exhibitions and public lectures. He was also an advocate of cancer research and served as an honorary chairman on the Breast Cancer Research Foundation's board of directors. In 1998, Lauder and his brother, Ronald S. Lauder, founded the Alzheimer's Drug Discovery Foundation, which supports drug research to prevent, treat and cure Alzheimer's. 'His impact will be felt for generations to come thanks to his tireless philanthropy, advocacy, and creativity in tackling some of the world's greatest challenges. The number of lives he touched and positively impacted across all his endeavors is immeasurable,' said Ronald Lauder, 81, who serves as chairman of Clinique Laboratories. The company's founding family remains the biggest shareholder in the firm, and three members serve on the board of directors. He is survived by his wife, Judy Glickman Lauder, and his sons William and Gary.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store